Beijing, China

Meina Li

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Institute of Pharmacology and Toxicology Academy of Military Medical Science P.l.a. China, Peking University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meina Li. Retrieved from https://idiyas.com/inventor/meina-li-sej5eazb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 20.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meina Li: Innovator in Medicinal Chemistry

Introduction

Meina Li is a prominent inventor based in Beijing, China. She has made significant contributions to the field of medicinal chemistry, particularly in the development of pharmaceutical compounds. Her work focuses on innovative solutions for treating diseases related to CCR (Chemokine Receptor).

Latest Patents

Meina Li holds a patent for "Piperazinyl pyrimidine derivatives, preparation method and use thereof." This patent includes piperazinyl pyrimidine derivatives of formula I that exhibit CCR antagonism. The preparation method, pharmaceutical composition, and applications of these derivatives are crucial for developing medicaments aimed at treating and preventing CCR-related diseases. She has 1 patent to her name.

Career Highlights

Throughout her career, Meina Li has worked with esteemed institutions such as the Institute of Pharmacology and Toxicology at the Academy of Military Medical Science, P.L.A. China, and Peking University. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Meina has collaborated with notable colleagues, including Song Li and Ying Wang. Their teamwork has fostered an environment of innovation and discovery in the field of pharmacology.

Conclusion

Meina Li's contributions to medicinal chemistry and her innovative patent demonstrate her commitment to advancing healthcare solutions. Her work continues to impact the treatment of CCR-related diseases, showcasing the importance of research and collaboration in scientific progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…